…significantly benefit from the treatment with the anti-hypertensive agent Valsartan, found to pharmacologically prevent beta-amyloid production in the brain even when delivered to Alzheimer’s disease mice at doses 3-4 fold lower than the minimal equivalent dose prescribed for the treatment of hypertension in humans. Other anti-hypertension drugs with beneficial results included Propranolol HCI, Carvedilol, Losartan, Nicardipine HCI, Amiloride HCI and Hydralazine HCI.

At this stage in the game this research is highly experimental but could help in the recent push into Alzheimer’s awareness and research. If you have an interest in Alzheimer’s disease please go see Mary Emma at our own Alzheimers Notes. To read more about this research..

Post from: Blisstree

Could Anti-Hypertensives Be Used To Treat Alzheimer’s Disease?

Over 55% of all emergent, as well as non emergent, patients that were hospital for hypertension in the state of Florida were whites. African American were in a distant second at just over 25% and Hispanic patients brought up the rear at just under 15%. Like I said above, I can personally think of many reasons that would lead to this conclusion but here is what the persons conducting the actual study came up with…

Study author WayWay Hlaing of Florida International University said the study of 7,102 patients revealed significant differences in length of stay, discharge status and insurance type among the three racial/ethnic groups.

Makes sense but what do you think? Do you feel that this would be indicative of the demographics of hypertensive in- patients in your neck of the woods?

via Science Daily

Post from: Blisstree

Hypertensive Care Based On Race